ArticlemedRxiv : the preprint server for health sciences2026
Genomic network analysis links uveitis with systemic inflammatory diseases.
Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Purpose: Uveitis is a vision-threatening inflammatory eye disease for which the cause is unknown and response to current therapies is limited. To better understand the genetic architecture of ocular inflammatory disease, we performed a computational synthesis and comparative network analysis of previously published GWAS significant variants associated with 1) uveitis, 2) ocular conditions including age-related and inherited retinal degeneration and 3) extraocular immune-mediated inflammatory diseases (IMIDs). Methods: We identified putative causal genes for genome-wide significance variants from uveitis, IMIDs and ocular diseases using OpenTargets and published studies. To assess the gene-level pleiotropy between disease groups, we quantified the causal gene overlap between groups, and the Jaccard Similarity Indices for individual disease pairs. We then used a network approach to assess the molecular genetic similarity between diseases at a biological pathway level and comparative statistics to identify diseases with greater network similarity to uveitis. Results: Seventy-five percent of the putative causal genes for uveitis were also implicated in IMIDs, while no uveitis genes were shared with primary ocular disorders. Network analysis revealed that 1) uveitis genes are more closely networked with systemic IMIDs disease genes than with ocular-specific disease genes; and 2) significant network similarity links uveitis and specific IMIDs, such as ankylosing spondylitis and sarcoidosis. Conclusions: Overlapping causal genes and network similarity suggest that uveitis is predominantly an inflammatory disease, sharing genetic architecture with other IMIDs. Translational Relevance: These findings provide a genomic framework for understanding the genetic drivers of ocular inflammation in uveitis and generate testable hypothesis for future studies aimed at rationally repurposing drugs from IMIDs for patients with uveitis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.